Illumina DRAGEN GCP Lvl 4 1-year License

The National Institute of Neurological Disorders and Stroke (NINDS) is seeking a one‑year subscription to Illumina’s DRAGEN GCP Level 4 platform to process ~1.3 PB of whole‑genome sequencing data from 10,000 human genomes. The award will be made on a sole‑source basis to Illumina, Inc. because the platform is the only solution meeting all technical and compatibility requirements. The contractor must provide continuous access and operational availability of the cloud‑based analysis system for the full performance period (09/30/2026 – 09/29/2027). • 12‑month license for DRAGEN GCP Level 4 (graph‑based alignment, variant calling, SV, CNV, repeat expansion detection) • Process ~1,300,000 GB of data (≈10,000 genomes) • Must be fully compatible with existing Illumina‑generated data and prior DRAGEN‑processed datasets • Sole‑source award to Illumina, Inc.; no competition required • Performance period: 09/30/2026 to 09/29/2027 (1 year) • Submission of capability statement/quote due 09/10/2026 (12:00 PM ET) via email to the contracting officer